{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T16:47:06Z","timestamp":1754153226602,"version":"3.41.2"},"reference-count":49,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Cir. Bras."],"abstract":"<jats:p>ABSTRACT  Purpose: To evaluate ceftriaxone\u2019s potential in enhancing peripheral nerve injuries (PNIs) recovery.  Methods: Thirty male Wistar rats were divided into control (no surgery), vehicle (sciatic nerve injury + 0.9% NaCl), and ceftriaxone (sciatic nerve injury + 50 mg\/kg\/day ceftriaxone) groups. Treatments were administered intraperitoneally for 12 weeks. Functional recovery was assessed using inclined plane tests and electromyography. Sciatic nerve regeneration was evaluated via histology, nerve growth factor (NGF) immunohistochemistry, and enzyme-linked immunosorbent assay.  Results: Compared to the control group, inclined plane test scores, nerve action potentials, NGF expression, axon counts, and diameters were diminished in both injury groups (p 0.001). However, these parameters were significantly improved in the ceftriaxone group compared to the vehicle group (p 0.001). Increased fibrosis was observed in the ceftriaxone group.  Conclusion: Ceftriaxone demonstrates potential as a pharmacological agent for PNI recovery by enhancing nerve regeneration and functional outcomes. Further studies are warranted to elucidate its mechanisms.<\/jats:p>","DOI":"10.1590\/acb404625","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T15:34:58Z","timestamp":1753198498000},"source":"Crossref","is-referenced-by-count":0,"title":["Peripheral nerve injury recovery enhanced by ceftriaxone: a preclinical investigation"],"prefix":"10.1590","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9409-1510","authenticated-orcid":false,"given":"Berkin","family":"Gunar","sequence":"first","affiliation":[{"name":"U\u015fak Banaz State Hospital,  Turkey; Marmara Un\u0131versity,  Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2448-2337","authenticated-orcid":false,"given":"Ejder Saylav","family":"Bora","sequence":"additional","affiliation":[{"name":"Izmir Katip \u00c7elebi University,  Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2452-1954","authenticated-orcid":false,"given":"Osman Mert","family":"Topkar","sequence":"additional","affiliation":[{"name":"Marmara Un\u0131versity,  Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5150-8857","authenticated-orcid":false,"given":"\u00d6zg\u00fcr","family":"Baysal","sequence":"additional","affiliation":[{"name":"Marmara Un\u0131versity,  Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1501-0108","authenticated-orcid":false,"given":"Ziya","family":"Shammadli","sequence":"additional","affiliation":[{"name":"Republican Clinical Hospital Named after G. G. Mirgasimov,  Azerbaijan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5427-8428","authenticated-orcid":false,"given":"Oytun","family":"Erbas","sequence":"additional","affiliation":[{"name":"Biruni University,  Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2025]]},"reference":[{"issue":"9","key":"ref1","doi-asserted-by":"crossref","first-page":"dev201164","DOI":"10.1242\/dev.201164","article-title":"The peripheral nervous system","volume":"150","author":"Murtazina A","year":"2023","journal-title":"Development"},{"issue":"5","key":"ref2","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/jnr.24538","article-title":"Peripheral nerve injury and myelination: Potential therapeutic strategies","volume":"98","author":"Modrak M","year":"2020","journal-title":"J Neurosci Res"},{"issue":"2","key":"ref3","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup NB","year":"2015","journal-title":"Lancet Neurol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.actbio.2020.02.003","article-title":"Nerve guide conduits for peripheral nerve injury repair: A review on design, materials and fabrication methods","volume":"106","author":"Vijayavenkataraman S","year":"2020","journal-title":"Acta Biomater"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2174\/1874325001408010199","article-title":"Peripheral nerve injury: principles for repair and regeneration","volume":"8","author":"Griffin M","year":"2014","journal-title":"Open Orthop J"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.injury.2022.01.031","article-title":"Approach to management of nerve gaps in peripheral nerve injuries","volume":"53","author":"Singh VK","year":"2022","journal-title":"Injury"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/mus.26188","article-title":"Regeneration of nerve crush injury using adipose-derived stem cells: A multimodal comparison","volume":"58","author":"Tremp M","year":"2018","journal-title":"Muscle Nerve"},{"issue":"10","key":"ref8","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.2174\/1570159X16666180412092859","article-title":"Nerve Growth factor: early studies and recent clinical trials","volume":"16","author":"Rocco ML","year":"2018","journal-title":"Curr Neuropharmacol"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"918","DOI":"10.3390\/ijms23020918","article-title":"Peripheral nerve injury treatments and advances: one health perspective","volume":"23","author":"Lopes B","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"7","key":"ref10","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.3390\/biomedicines10071678","article-title":"Review of drug therapy for peripheral facial nerve regeneration that can be used in actual clinical practice","volume":"10","author":"Choi SY","year":"2022","journal-title":"Biomedicines"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/0897190014544798","article-title":"Ceftriaxone potentiates warfarin activity greater than other antibiotics in the treatment of urinary tract infections","volume":"29","author":"Saum LM","year":"2016","journal-title":"J Pharm Pract"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"12000","DOI":"10.1038\/s41598-022-16132-3","article-title":"Ceftriaxone resistance among patients at GAMBY Teaching General Hospital","volume":"12","author":"Gelaw LY","year":"2022","journal-title":"Sci Rep"},{"issue":"12","key":"ref13","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1093\/carcin\/bgs283","article-title":"Ceftriaxone, an FDA-approved cephalosporin antibiotic, suppresses lung cancer growth by targeting Aurora B","volume":"33","author":"Li X","year":"2012","journal-title":"Carcinogenesis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"736786","DOI":"10.3389\/fnins.2021.736786","article-title":"Neuroprotective effects of ceftriaxone involve the reduction of a\u03b2 burden and neuroinflammatory response in a mouse model of Alzheimer\u2019s Disease","volume":"15","author":"Tikhonova MA","year":"2021","journal-title":"Front Neurosci"},{"issue":"6","key":"ref15","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/jnc.13200","article-title":"Current approaches to enhance glutamate transporter function and expression","volume":"134","author":"Fontana AC","year":"2015","journal-title":"J Neurochem"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1601-5215.2012.00656.x","article-title":"Antiallodynia and antihyperalgesia effects of ceftriaxone in treatment of chronic neuropathic pain in rats","volume":"25","author":"Hajhashemi V","year":"2013","journal-title":"Acta Neuropsychiatr"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/TA.0b013e31825133c0","article-title":"The beta-lactam antibiotic, ceftriaxone, provides neuroprotective potential via anti-excitotoxicity and anti-inflammation response in a rat model of traumatic brain injury","volume":"73","author":"Wei J","year":"2012","journal-title":"J Trauma Acute Care Surg"},{"issue":"11","key":"ref18","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1093\/cercor\/bhy328","article-title":"Ceftriaxone treatment preserves cortical inhibitory interneuron function via transient salvage of GLT-1 in a rat traumatic brain injury model","volume":"29","author":"Hameed MQ","year":"2019","journal-title":"Cereb Cortex"},{"issue":"16","key":"ref19","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1089\/neu.2012.2712","article-title":"Ceftriaxone treatment after traumatic brain injury restores expression of the glutamate transporter, GLT-1, reduces regional gliosis, and reduces post-traumatic seizures in the rat","volume":"30","author":"Goodrich GS","year":"2013","journal-title":"J Neurotrauma"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/jnr.23295","article-title":"Upregulation of GLT-1 by treatment with ceftriaxone alleviates radicular pain by reducing spinal astrocyte activation and neuronal hyperexcitability","volume":"92","author":"Nicholson KJ","year":"2014","journal-title":"J Neurosci Res"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.neuroscience.2010.06.014","article-title":"Spinal upregulation of glutamate transporter GLT-1 by ceftriaxone: therapeutic efficacy in a range of experimental nervous system disorders","volume":"169","author":"Ramos KM","year":"2010","journal-title":"Neuroscience"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"189","DOI":"10.15171\/apb.2015.026","article-title":"Comparative study on the effects of ceftriaxone and monocytes on recovery after spinal cord injury in rat","volume":"5","author":"Tajkey J","year":"2015","journal-title":"Adv Pharm Bull"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0014-4886(86)90161-5","article-title":"Motoneurons of the rat sciatic nerve","volume":"93","author":"Swett JE","year":"1986","journal-title":"Exp Neurol"},{"issue":"1-2","key":"ref24","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford MM","year":"1976","journal-title":"Anal Biochem"},{"issue":"11","key":"ref25","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.2174\/1570159X18666200507084024","article-title":"Recent findings on the effects of pharmacological agents on the nerve regeneration after peripheral nerve injury","volume":"18","author":"Bolandghamat S","year":"2020","journal-title":"Curr Neuropharmacol"},{"issue":"4","key":"ref26","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3171\/jns.1977.47.4.0577","article-title":"Objective clinical assessment of motor function after experimental spinal cord injury in the rat","volume":"47","author":"Rivlin AS","year":"1977","journal-title":"J Neurosurg"},{"issue":"6","key":"ref27","doi-asserted-by":"crossref","first-page":"873","DOI":"10.3340\/jkns.2021.0078","article-title":"The restorative effect of gallic acid on the experimental sciatic nerve damage model","volume":"64","author":"Gurkan G","year":"2021","journal-title":"J Korean Neurosurg Soc"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.expneurol.2013.05.007","article-title":"Schwann cell phenotype is regulated by axon modality and central-peripheral location, and persists in vitro","volume":"247","author":"Brushart TM","year":"2013","journal-title":"Exp Neurol"},{"issue":"18","key":"ref29","doi-asserted-by":"crossref","first-page":"5698","DOI":"10.1523\/JNEUROSCI.16-18-05698.1996","article-title":"Reinnervation accuracy of the rat femoral nerve by motor and sensory neurons","volume":"16","author":"Madison RD","year":"1996","journal-title":"J Neurosci"},{"issue":"6","key":"ref30","first-page":"5343","article-title":"Therapeutic Efficacy of Digoxin in Oxaliplatin and Chronic Constriction Injury Model of Neuropathic Pain in Rats","volume":"38","author":"Saraswati Patel","year":"2024","journal-title":"Journal of Biological Regulators and Homeostatic Agents"},{"issue":"5","key":"ref31","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1177\/0748233713511513","article-title":"Neuroprotective effects of folic acid on experimental diabetic peripheral neuropathy","volume":"32","author":"Yilmaz M","year":"2013","journal-title":"Toxicol Ind Health"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1021\/cn200072h","article-title":"Ceftriaxone ameliorates motor deficits and protects dopaminergic neurons in 6-hydroxydopamine-lesioned rats","volume":"3","author":"Leung TC","year":"2012","journal-title":"ACS Chem Neurosci"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.neuro.2014.05.009","article-title":"Ceftriaxone mediated rescue of nigral oxidative damage and motor deficits in MPTP model of Parkinson\u2019s disease in rats","volume":"44","author":"Bisht R","year":"2014","journal-title":"Neurotoxicology"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12868-021-00659-8","article-title":"Ceftriaxone therapy attenuates brain trauma in rats by affecting glutamate transporters and neuroinflammation and not by its antibacterial effects","volume":"22","author":"Lim SW","year":"2021","journal-title":"BMC Neurosci"},{"issue":"3","key":"ref35","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00210-016-1332-5","article-title":"Nephroprotective efficacy of ceftriaxone against cisplatin-induced subchronic renal fibrosis in rats","volume":"390","author":"Abdel-Daim MM","year":"2017","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"3","key":"ref36","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1460-9568.1994.tb00278.x","article-title":"Effects of transforming growth factor beta 1 on scar production in the injured central nervous system of the rat","volume":"6","author":"Logan A","year":"1994","journal-title":"Eur J Neurosci"},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12891-016-1383-2","article-title":"Accuracy of clinical neurological examination in diagnosing lumbo-sacral radiculopathy: a systematic literature review","volume":"18","author":"Tawa N","year":"2017","journal-title":"BMC Musculoskelet Disord"},{"issue":"5","key":"ref38","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1080\/01480545.2021.1914464","article-title":"Neuroprotective effects of dexpanthenol on streptozotocin-induced neuronal damage in rats","volume":"45","author":"Erdogan MA","year":"2022","journal-title":"Drug Chem Toxicol"},{"issue":"2","key":"ref39","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/ejp.1117","article-title":"The \u03b2-lactam clavulanic acid mediates glutamate transport-sensitive pain relief in a rat model of neuropathic pain","volume":"22","author":"Kristensen PJ","year":"2018","journal-title":"Eur J Pain"},{"key":"ref40","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9424582","article-title":"Neuroprotective effect of ceftriaxone on MPTP-induced Parkinson\u2019s disease mouse model by regulating inflammation and intestinal microbiota","volume":"2021","author":"Zhou X","year":"2021","journal-title":"Oxid Med Cell Longev"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3389\/fnins.2019.00236","article-title":"Repurposing of the \u03b2-lactam antibiotic, ceftriaxone for neurological disorders: a review","volume":"13","author":"Yimer EM","year":"2019","journal-title":"Front Neurosci"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nature03180","article-title":"Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression","volume":"433","author":"Rothstein JD","year":"2005","journal-title":"Nature"},{"issue":"10","key":"ref43","first-page":"1813","article-title":"Pictorial review of glutamate excitotoxicity: fundamental concepts for neuroimaging","volume":"22","author":"Mark LP","year":"2001","journal-title":"AJNR Am J Neuroradiol"},{"issue":"5","key":"ref44","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s10072-013-1585-4","article-title":"Neuroprotective effect of ceftriaxone in a rat model of traumatic brain injury","volume":"35","author":"Cui C","year":"2014","journal-title":"Neurol Sci"},{"issue":"16","key":"ref45","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1089\/neu.2012.2712","article-title":"Ceftriaxone treatment after traumatic brain injury restores expression of the glutamate transporter, GLT-1, reduces regional gliosis, and reduces post-traumatic seizures in the rat","volume":"30","author":"Goodrich GS","year":"2013","journal-title":"J Neurotrauma"},{"key":"ref46","doi-asserted-by":"crossref","DOI":"10.1590\/acb387823","article-title":"Autophagy and anti-inflammation ameliorate diabetic neuropathy with Rilmenidine","volume":"38","author":"Yal\u00e7\u0131n MB","year":"2023","journal-title":"Acta Cir Bras"},{"issue":"3","key":"ref47","doi-asserted-by":"crossref","first-page":"294","DOI":"10.2174\/1570159X13666150403231920","article-title":"Nerve growth factor: a focus on neuroscience and therapy","volume":"13","author":"Aloe L","year":"2015","journal-title":"Curr Neuropharmacol"},{"issue":"39","key":"ref48","doi-asserted-by":"crossref","first-page":"13222","DOI":"10.1523\/JNEUROSCI.1209-13.2014","article-title":"Peripheral nerve regeneration and NGF-dependent neurite outgrowth of adult sensory neurons converge on STAT3 phosphorylation downstream of neuropoietic cytokine receptor gp130","volume":"34","author":"Quarta S","year":"2014","journal-title":"J Neurosci"},{"issue":"36","key":"ref49","first-page":"3416","article-title":"Sciatic nerve regeneration using a nerve growth factor-containing fibrin glue membrane","volume":"8","author":"Ma S","year":"2013","journal-title":"Neural Regen Res"}],"container-title":["Acta Cir\u00fargica Brasileira"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0102-86502025000100228&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T16:50:16Z","timestamp":1753203016000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0102-86502025000100228&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":49,"alternative-id":["S0102-86502025000100228"],"URL":"https:\/\/doi.org\/10.1590\/acb404625","relation":{},"ISSN":["1678-2674","0102-8650"],"issn-type":[{"type":"electronic","value":"1678-2674"},{"type":"print","value":"0102-8650"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"e404625"}}